Pediculosis Clinical Trial
Official title:
A Randomized, Single-Dose, Parallel Group, Comparative Pharmacokinetic (PK) Study to Evaluate Malathion Gel 0.5% Versus Ovide (Malathion) Lotion 0.5% in Patients With Pediculosis Capitis
In this study, 24 adult patients with head lice will be treated with a topical malathion head lice treatment; 12 patients will be treated with a novel product, Malathion Gel, 0.5%, and other 12 patients will be treated with Ovide Lotion 0.5% marketed by Taro Pharmaceuticals USA, Inc. The primary objective of this study is to compare the blood level exposure of Malathion 0.5% Gel to that of the OVIDE Lotion 0.5%.
A randomized, single-dose, parallel group, comparative PK study. Patients will be randomly assigned in 1:1 ratio to the study products. Twenty four (24) consenting patients, age 18 years and older, who meet Inclusion/Exclusion criteria will be enrolled in this study. 12 Patients will be treated with Malathion Gel, 0.5% and other 12 Patients will be treated with Ovide Lotion 0.5%. The study will be single centre and conducted only in India. The primary objective of this study is to compare the systemic exposure of Malathion 0.5% Gel manufactured by Taro Pharmaceuticals USA, Inc. to that of the OVIDE Lotion 0.5%, currently marketed by Taro Pharmaceutical USA, Inc., in adult Patients with head lice. The secondary objective is to determine the link between the exposure and cholinesterase activity. ;
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01660321 -
Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
|
Phase 4 | |
Completed |
NCT00752973 -
Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
|
Phase 2/Phase 3 | |
Completed |
NCT00545753 -
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
|
Phase 3 | |
Completed |
NCT00381082 -
A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.
|
Phase 2/Phase 3 | |
Terminated |
NCT02499549 -
Two Treatment Regimens of Cocamide DEA Lotion for Head Lice
|
Phase 2/Phase 3 | |
Completed |
NCT05643820 -
Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis
|
Phase 1 | |
Completed |
NCT00731718 -
Control of Head Lice Infestations in Children and Adults
|
N/A | |
Not yet recruiting |
NCT01966965 -
Efficacy and Safety Study for PIOLIN® Shampoo
|
Phase 3 | |
Completed |
NCT01518699 -
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00207753 -
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
|
N/A | |
Completed |
NCT00927472 -
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
|
Phase 3 | |
Completed |
NCT00963508 -
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
|
Phase 3 | |
Completed |
NCT01336647 -
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
|
Phase 2 |